Ari M Cedars1, Ada Stefanescu Schmidt2, Craig Broberg2, Ali Zaidi2, Alexander Opotowsky2, Jasmine Grewal2, Joseph Kay2, Ami B Bhatt2, Eric Novak2, John Spertus2. 1. From the Baylor University Medical Center, Dallas, TX (A.M.C.); Massachusetts General Hospital, Boston (A.S., A.B.); Oregon Health Sciences University, Portland (C.B.); Montefiore Medical Center, New York, NY (A.Z.); Boston Children's Hospital, MA (A.O.); University of British Columbia, Vancouver (J.G.); University of Colorado, Denver (J.K.); Washington University, St. Louis, MO (E.N.); and St. Luke's Mid-America Heart Institute, Kansas City, KS (J.S.). acedars@dom.wustl.edu. 2. From the Baylor University Medical Center, Dallas, TX (A.M.C.); Massachusetts General Hospital, Boston (A.S., A.B.); Oregon Health Sciences University, Portland (C.B.); Montefiore Medical Center, New York, NY (A.Z.); Boston Children's Hospital, MA (A.O.); University of British Columbia, Vancouver (J.G.); University of Colorado, Denver (J.K.); Washington University, St. Louis, MO (E.N.); and St. Luke's Mid-America Heart Institute, Kansas City, KS (J.S.).
Abstract
BACKGROUND: There is a lack of objective data on the symptoms characterizing disease activity among adults with congenital heart disease (ACHD). The purpose of this study was to elicit the most important symptoms from patients across the spectrum of ACHD and to examine whether reported symptoms were similar across the spectrum of ACHD as a foundation for creating a patient-reported outcome measure(s). METHODS AND RESULTS: We constructed a 39-item survey using input from physicians specializing in ACHD to assess the symptoms patients associate with disease activity. Patients (n=124) prospectively completed this survey, and the results were analyzed based on underlying anatomy and disease complexity. A confirmatory cohort of patients (n=40) was then recruited prospectively to confirm the validity of the initial data. When grouped based on underlying anatomy, significant differences in disease-related symptom rankings were found for only 6 of 39 symptoms. Six symptoms were identified which were of particular significance to patients, regardless of underlying anatomy. Patients with anatomy of great complexity experienced greater overall symptom severity than those with anatomy of low or moderate complexity, attributable exclusively to higher ranking of 5 symptoms. The second patient cohort had symptom experiences similar to those of the initial cohort, differing in only 5 of 39 symptoms. CONCLUSIONS: This study identified 6 symptoms relevant to patients across the spectrum of ACHD and remarkable homogeneity of patient experience, suggesting that a single disease-specific patient-reported outcome can be created for quality and outcome assessments.
BACKGROUND: There is a lack of objective data on the symptoms characterizing disease activity among adults with congenital heart disease (ACHD). The purpose of this study was to elicit the most important symptoms from patients across the spectrum of ACHD and to examine whether reported symptoms were similar across the spectrum of ACHD as a foundation for creating a patient-reported outcome measure(s). METHODS AND RESULTS: We constructed a 39-item survey using input from physicians specializing in ACHD to assess the symptoms patients associate with disease activity. Patients (n=124) prospectively completed this survey, and the results were analyzed based on underlying anatomy and disease complexity. A confirmatory cohort of patients (n=40) was then recruited prospectively to confirm the validity of the initial data. When grouped based on underlying anatomy, significant differences in disease-related symptom rankings were found for only 6 of 39 symptoms. Six symptoms were identified which were of particular significance to patients, regardless of underlying anatomy. Patients with anatomy of great complexity experienced greater overall symptom severity than those with anatomy of low or moderate complexity, attributable exclusively to higher ranking of 5 symptoms. The second patient cohort had symptom experiences similar to those of the initial cohort, differing in only 5 of 39 symptoms. CONCLUSIONS: This study identified 6 symptoms relevant to patients across the spectrum of ACHD and remarkable homogeneity of patient experience, suggesting that a single disease-specific patient-reported outcome can be created for quality and outcome assessments.
Authors: Petra Opić; Jolien W Roos-Hesselink; Judith A A C Cuypers; Maarten Witsenburg; Annemien van den Bosch; Ron T van Domburg; Ad J J C Bogers; Elisabeth M W J Utens Journal: Int J Cardiol Date: 2013-07-13 Impact factor: 4.164
Authors: Carole A Warnes; Roberta G Williams; Thomas M Bashore; John S Child; Heidi M Connolly; Joseph A Dearani; Pedro Del Nido; James W Fasules; Thomas P Graham; Ziyad M Hijazi; Sharon A Hunt; Mary Etta King; Michael J Landzberg; Pamela D Miner; Martha J Radford; Edward P Walsh; Gary D Webb Journal: J Am Coll Cardiol Date: 2008-12-02 Impact factor: 24.094
Authors: Harald Kaemmerer; Ulrike Bauer; Ulrike Pensl; Erwin Oechslin; Verena Gravenhorst; Andreas Franke; Alfred Hager; Gunter Balling; Michael Hauser; Andreas Eicken; John Hess Journal: Am J Cardiol Date: 2007-12-26 Impact factor: 2.778
Authors: Dounya Schoormans; Barbara J M Mulder; Joost P van Melle; Petronella G Pieper; Arie P J van Dijk; Gertjan Tj Sieswerda; Mariët S Hulsbergen-Zwarts; Thijs H W M Plokker; Leo G H Brunninkhuis; Hubert W Vliegen; Mirjam A G Sprangers Journal: Eur J Cardiovasc Nurs Date: 2013-03-22 Impact factor: 3.908
Authors: Ari M Cedars; Jong Mi Ko; Anitha S John; Jeffrey Vittengl; Ada C Stefanescu-Schmidt; Robin B Jarrett; Shelby Kutty; John A Spertus Journal: J Am Heart Assoc Date: 2020-05-16 Impact factor: 5.501